Condition: Coronary Artery Disease · Sponsor: Fundación EPIC
International, investigator-driven, multicenter, open-label, prospective randomized controlled trial where patients with de novo lesions due to calcified nodules (CN) were randomized to drug eluting balloon (DEB) or drug eluting stents (DES).
This description comes directly from the study's public registry record.
FUNDACION EPIC · 0034987225638 · iepic@fundacionepic.org
ALFONSO JURADO ROMAN, MD,PhD · alfonsojuradoroman@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital Del Mar | Barcelona, Spain | Recruiting |
| Hospital Universitario de La Paz | Fuencarral-El Pardo, Spain | Recruiting |
| Hospital Universitario de Galdakao-Usansolo | Galdakao, Spain | Recruiting |
| Hospital Universitario de León | León, Spain | Recruiting |
| Hospital Universitario 12 de Octubre | Madrid, Spain | Recruiting |
| Hospital Universitario Puerta de Hierro | Madrid, Spain | Recruiting |
| Hospital Clínico San Carlos | Moncloa-Aravaca, Spain | Recruiting |
| Hospital Universitario de Navarra | Pamplona, Spain | Recruiting |
| Hospital General Universitario de Valencia | Valencia, Spain | Recruiting |
| Hospital Universitario y Politécnico La Fe | Valencia, Spain | Recruiting |
| Hospital Clínico Universitario de Valladolid | Valladolid, Spain | Recruiting |
| Hospital Universitario de Vigo | Vigo, Spain | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06657833